We have some exciting news—as well as some rather disturbing news to announce.
First, the exciting news:
1. USA Television Premiere of Burzynski, the Movie: Cancer Is Serious Business on The Documentary Channel!
Sunday, August 7, 2011 at 8:00 PM Eastern:
2. Canada & USA TV pay-per-view available August 1, 2011 through October 31, 2011 only, via multiple TV platforms:
(a). Pay-per-view within the USA on the following TV subscription services:
Verizon FiOs, Charter, AT&T U-Verse, Dish, Mediacom, Eastlink Communications, Wave, Blue Ridge, Burlington Telecom, Morristown, KPU, Tullahoma Utilities, Valley Communications.
(b). Pay-per-view within Canada via the following TV subscription services:
Rogers, Cogeco, Access Communication, Source Cable, NorthwsTel Cable, Bluewater, Seaside, Cable Cable.
3. More online rental and purchase starting August 1st:
iTunes, Vudu.com, CinemaNow.com (Netflix coming this fall).
If you have already seen this film, we hope that you encourage a friend to see it—seeing it has become easier and easier for everyone! As Dr. Burzynski, Antineoplastons, and this film project continues to gain more momentum within the worldwide public eye, more and more distribution outlets have opened up.
This is a good thing, not just because it exposes more people to this story, but because we are going to need you and everyone else that cares about medical freedom and the preservation of Dr. Burzynski, his clinic, and Antineoplastons to soon step up to the plate to help, because...
4. We have some disturbing news:
The Texas Medical Board is trying once again to shut Burzynski's clinic down. In January 2012 they will take him to trial—again. We will be launching a new call-to-action to bombard Governor Rick Perry's office, with letters, emails, faxes, phone calls and DVDs to keep this trial from going forward. Please sit tight, we will have a fully targeted package to utilize to try to help fight this absurdity.
As a part of this call-to-action, we will also be asking people to bug all of our Congressman and Senators to open up a new hearing to force the FDA to allow the approval of Antineoplastons based on their completed Phase 2 FDA clinical trials. Almost all cancer drugs approved in the last decade were approved after only completing Phase 2 FDA trials, especially for brain cancer. To make matters worse, nearly all of these drugs were approved after completing Phase 2 without having saved a single life. Yet, Burzynski & Antineoplastons are credited with saving hundreds of lives in Phase 2 FDA clinical trials, including the lives of pediatric brain cancer patients—who have not only been alive for over 10 years—but are the first patients in the history of medicine to ever have been cured of their type of tumor.
There is no logical reason other than outright bureaucratic suppression to force Antineoplastons to enter Phase 3 trials without hitting the market first after completing Phase 2. Not to mention the $300 million dollar price tag that Phase 3 trials cost, which can be more easily paid for if the FDA would allow them on the market—allowing The Burzynski Research Institute, Inc. and other third-party distributors to profit from it, then turning that money into funding for Phase 3.
Allowing drugs to be FDA approved after completing only Phase 2 is not remotely unusual. What the FDA does is approve these drugs after Phase 2, then while they are on the market they simultaneously conduct Phase 3. But, not for Burzynski, Antineoplastons, or cancer patients that need this treatment now.
We will have a well-buttoned up fact sheet and form letters to write your local Congressmen and Senators to push this forward. The truth is on our side, and all we are asking is to make the FDA consider Antineoplastons no differently than they have considered any other drug on the market.
If we put the FDA on the stand today, we can not only expose this abuse of power—but participate in the first time in history the general public will be responsible for forcing a medicine into FDA-approval and into the public's hands. (That's almost as exciting as discovering a cure for cancer).
RSS Feed